These chemokines facilitate angiogenesis and promote the recruitment of neutrophils and Th17 cells.[44] A clinical study identified the candidate gene CXCL11 as a potential therapeutic target for rosacea using bioinformatics methods.[45] This finding aligns with our research results, which indicate that CXCL11 elevates the risk of rosacea development. This evidence concerns the gene CXCL11 and rosacea.